Tiantian Wei

Tiantian Wei

Auto-generated profile, based on publicly available information

Tiantian Wei

The State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2024 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
XZXin Zeng
Xin Zeng
TWTiantian Wei
Tiantian Wei
XWXianghe Wang
Xianghe Wang
YLYuan Liu
Yuan Liu
ZTZhenshu Tan
Zhenshu Tan
CWChu Wang
Chu Wang

7 March 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
TWTiantian Wei
Tiantian Wei
YZYaqin Zhu
Yaqin Zhu
Gaigai DuanGaigai Duan
Gaigai Duan
JHJingquan Han
Jingquan Han
Xiaoshuai HanXiaoshuai Han
Xiaoshuai Han
Shaohua JiangShaohua Jiang
Shaohua Jiang


26 May 2021 in Cytotechnology
Verified
Journal Article
Open access
PDF file
GMGuangzhen Ma
Guangzhen Ma
JCJirong Chen
Jirong Chen
TWTiantian Wei
Tiantian Wei
JWJia Wang
Jia Wang
WCWenshan Chen
Wenshan Chen
Forkhead box A2 (FOXA2) has emerged as a tumor inhibitor in several human malignancies. This work focused on the effect of FOXA2 on liver cancer (LC) cell invasion and migration and the involving molecules. FOXA2 expression in LC tissues and cell lines was determined. The potential target microRNA (miRNA) of FOXA2 was predicted via bioinformatic analysis and validated through a ChIP assay. The mRNA target of miRNA-103a-3p was predicted via bioinformatic analysis and confirmed via a luciferase assay. Altered expression of FOXA2, miR-103a-3p and GREM2 was introduced in cells to identify their roles in LC cell migration and invasion. Consequently, FOXA2 and GREM2 were poorly expressed while miR-103a-3p was highly expressed in LC samples. Overexpression of FOXA2 or GREM2 suppressed migration and invasion of LC cells, while up-regulation of miR-103a-3p led to inverse trends. FOXA2 transcriptionally suppressed miR-103a-3p to increase GREM2 expression. Silencing of GREM2 blocked the effects of FOXA2. GREM2 increased LATS2 activity and YAP phosphorylation and degradation. To conclude, this study demonstrated that FOXA2 suppressed miR-103a-3p transcription to induce GREM2 upregulation, which increased LATS2 activity and YAP phosphorylation to inhibit migration and invasion of LC cells.

19 April 2022 in eLife
Verified
Journal Article
Open access
TWTiantian Wei
Tiantian Wei
JWJue Wang
Jue Wang
RLRuqi Liang
Ruqi Liang
WCWendong Chen
Wendong Chen
YCYilan Chen
Yilan Chen
XLXiaoguang Lei
Xiaoguang Lei
The dual-specificity tyrosine phosphorylation-regulated kinase DYRK2 has emerged as a critical regulator of cellular processes. We took a chemical biology approach to gain further insights into its function. We developed C17, a potent small-molecule DYRK2 inhibitor, through multiple rounds of structure-based optimization guided by several co-crystallized structures. C17 displayed an effect on DYRK2 at a single-digit nanomolar IC50 and showed outstanding selectivity for the human kinome containing 467 other human kinases. Using C17 as a chemical probe, we further performed quantitative phosphoproteomic assays and identified several novel DYRK2 targets, including eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) and stromal interaction molecule 1 (STIM1). DYRK2 phosphorylated 4E-BP1 at multiple sites, and the combined treatment of C17 with AKT and MEK inhibitors showed synergistic 4E-BP1 phosphorylation suppression. The phosphorylation of STIM1 by DYRK2 substantially increased the interaction of STIM1 with the ORAI1 channel, and C17 impeded the store-operated calcium entry process. These studies collectively further expand our understanding of DYRK2 and provide a valuable tool to pinpoint its biological function.

12 March 2024 in Vaccine
Verified
Journal Article
Closed access
TXTing Xu
Ting Xu
AHAncan Hong
Ancan Hong
XZXueli Zhang
Xueli Zhang
YXYizhou Xu
Yizhou Xu
TWTao Wang
Tao Wang
Tao QinTao Qin
Tao Qin